Crispr’s Next Big Debate: How Messy Is Too Messy?
Jun 07, 2017•9 min
Episode description
When it comes toCrispr, the bacterial wünderenzyme that allows scientists to precisely edit DNA, no news is too small to stir up some drama. On Tuesday morning, doctors from Columbia, Stanford, and the University of Iowa published a one-page letterto the editor of Nature Methods—an obscure but high-profile journal—describing something downright peculiar.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android
